A case of ventricular fibrillation as a consequence of capecitabine-induced secondary QT prolongation: A case report

Capecitabine is an oral fluoropyrimidine which can prolong QT interval. However, there have been no reports that capecitabine induced ventricular fibrillation (VF) due to secondary QT prolongation in patients with no structural heart disease. A 39-year-old woman developed VF during the chemotherapy...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Cardiol Cases
Glavni autori: Hayasaka, Kazuto, Takigawa, Masateru, Takahashi, Atsushi, Kuwahara, Taishi, Okubo, Kenji, Tanaka, Yasuaki, Misawa, Toru, Mizusawa, Masafumi, Yamakami, Yosuke, Kojima, Keisuke, Sagawa, Yuichiro, Hishikari, Keiichi, Yamao, Kazuya, Nakashima, Emiko, Nakajima, Jun, Kimura, Shigeki, Takagi, Katsumasa, Hikita, Hiroyuki, Isobe, Mitsuaki
Format: Artigo
Jezik:Inglês
Izdano: Japanese College of Cardiology 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149258/
https://ncbi.nlm.nih.gov/pubmed/30279790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2017.03.009
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items